adc scale-up in a gmp environment
Published 2 months ago • 16 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
5:57
characterization of antibody-drug conjugates (adc)
-
1:01:10
the abcs of adc characterisation
-
9:24
the development of a next generation antibody drug conjugate adc
-
6:48
orchestrating a multi-part adc contract manufacturing landscape
-
14:44
cmc bottlenecks and tech transfer strategy in adc development
-
30:15
manufacturing concepts for antibody-drug conjugates | webinar
-
2:22
how do adc technologies and services speed up the manufacturing process?
-
1:58
elon musk fires employees in twitter meeting dub
-
3:01
going from stage iv lung cancer to clean scans
-
34:15
joseph ferra & dr david dornan; elevation oncology; precision oncology with antibody drug conjugates
-
7:29
antibody-drug conjugates - where are we going?
-
1:55
smartag® technology: a site-specific approach to making adcs
-
41:27
taking adcs across the finish line
-
2:43
connect the dots: adc conjugation
-
2:41
how do antibody-drug conjugates adcs work?
-
3:33
what are antibody-drug conjugates (adcs)?
-
56:39
accelerating adcs with mythic therapeutics' brian fiske, ph.d.
-
6:00
achieving gmp quality in protein manufacturing with aldevron
-
1:15
jk06, a biparatopic adc in preclinical development
-
18:14
in-depth characterization of lysine-conjugated antibody-drug conjugates (adcs) by multiplexed ms/ms
-
15:20
reducing risk and improving timelines in the design, development, and manufacture of antibody...